JPRN-jRCT2080221661未知2 期
A phase 2 study to evaluate the efficacy and safety of K-134 for the treatment of intermittent claudication
适应症
试验速览
- 阶段
- 2 期
- 入组人数
- 330
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 50age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Patients with intermittent claudication secondary to peripheral arterial disease
排除标准
- •Patients with critical limb ischemia, patients with congestive heart failure
研究者
相似试验
招募中
1 期
A phase 2 study of ianalumab (VAY736) in patients with primary immune thrombocytopenia (ITP) previously treated with at least two lines of therapiesCTIS2022-503041-21-00ovartis Pharma AG40
招募中
不适用
A phase 2 study to evaluate the efficacy and safety of temozolomide in advanced gastrointestinal stromal tumor patients with SDH deficiencyKCT0008244Asan Medical Center29
进行中（未招募）
1 期
A Phase 2 study to evaluate the efficacy and safety of selinexor monotherapy in subjectswith JAK inhibitor-naïve myelofibrosis and moderate thrombocytopenia.moderate thrombocytopenia, JAK inhibitor-naïve myelofibrosisMedDRA version: 20.0Level: PTClassification code: 10043554Term: Thrombocytopenia Class: 100000004851MedDRA version: 20.0Level: PTClassification code: 10028537Term: Myelofibrosis Class: 100000004864CTIS2024-511309-47-00Karyopharm Therapeutics Inc.58
进行中（未招募）
1 期
A Phase 2 study to evaluate the efficacy and safety of RPT193 in adults with moderate-to-severe T2-high asthma who are partially controlled on inhaled corticosteroid and long-acting beta 2 agonist therapyAsthmaCTIS2022-502854-16-00Rapt Therapeutics Inc.100
招募中
2 期
Effect of tranilast on facial neuralgiaTrigeminal neuralgiaTrigeminal neuropathic painTrigeminal NeuralgiaJPRN-jRCTs061230013Ikutame Daisuke15